Umlaut.bio

Developer of small-molecule therapeutics for cancer

placeAschaffenburg, Bavaria, Germany calendar_todayFounded 2022 language umlaut.bio

Registered entities

Social engagement

Social engagement: 717 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

19 Feb 2026
Partnership
BaseLaunch and Prof. Distler and Prof. Suzuki
Coming soon